Nuvation Bio (NUVB) Profit After Tax (2023 - 2025)
Historic Profit After Tax for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.
- Nuvation Bio's Profit After Tax fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
- Nuvation Bio's Profit After Tax amounted to -$55.8 million in Q3 2025, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
- Nuvation Bio's Profit After Tax's 5-year high stood at -$13.8 million during Q4 2023, with a 5-year trough of -$462.5 million in Q2 2024.
- Moreover, its 3-year median value for Profit After Tax was -$41.2 million (2024), whereas its average is -$73.8 million.
- In the last 5 years, Nuvation Bio's Profit After Tax crashed by 214075.58% in 2024 and then soared by 8724.15% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Profit After Tax stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
- Its Profit After Tax was -$55.8 million in Q3 2025, compared to -$59.0 million in Q2 2025 and -$53.2 million in Q1 2025.